Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Chung

Showing results (201-210 of 237) with videos related to

Pageof 24
Sort By:
European Urology Oncology|May 7, 2025
Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate CancerNoelia Sanmamed, Ian Dayes, Charles Catton, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 3, 2025
2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancerGirish S Kulkarni, Peter C Black, Srikala S Sridhar, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or BrachytherapyWei Liu, Katherine Zukotynski, Louise Emmett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
Canadian consensus guidelines for the management of testicular germ cell cancerLori Wood, Christian Kollmannsberger, Michael Jewett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 27, 2022
Canadian Urological Association consensus guideline: Management of testicular germ cell cancerRobert J Hamilton, Christina Canil, Noa Shani Shrem, et al.
The Journal of Urology|February 24, 2018
Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell TumorRicardo Leão, Ton van Agthoven, Arnaldo Figueiredo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomesJohn Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
Neuro-Oncology Advances|May 19, 2025
Survival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysisKurl Jamora, Adeodatus Vito Nicanor, Ayah Erjan, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 6, 2024
Prospective evaluation of patient-reported anxiety and experiences with adaptive radiation therapy on an MR-linacAmanda Moreira, Winnie Li, Alejandro Berlin, et al.
Pageof 24

Showing results (201-210 of 237) with videos related to

Sort By:
Pageof 24
European Urology Oncology|May 7, 2025
Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate CancerNoelia Sanmamed, Ian Dayes, Charles Catton, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 3, 2025
2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancerGirish S Kulkarni, Peter C Black, Srikala S Sridhar, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or BrachytherapyWei Liu, Katherine Zukotynski, Louise Emmett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
Canadian consensus guidelines for the management of testicular germ cell cancerLori Wood, Christian Kollmannsberger, Michael Jewett, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 27, 2022
Canadian Urological Association consensus guideline: Management of testicular germ cell cancerRobert J Hamilton, Christina Canil, Noa Shani Shrem, et al.
The Journal of Urology|February 24, 2018
Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell TumorRicardo Leão, Ton van Agthoven, Arnaldo Figueiredo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2026
Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomesJohn Mohan Mathew, Hannah Bacon, Jeff Winter, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
Neuro-Oncology Advances|May 19, 2025
Survival outcomes and clinical characteristics of brain metastases from prostate cancer: A single-center analysisKurl Jamora, Adeodatus Vito Nicanor, Ayah Erjan, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 6, 2024
Prospective evaluation of patient-reported anxiety and experiences with adaptive radiation therapy on an MR-linacAmanda Moreira, Winnie Li, Alejandro Berlin, et al.
Pageof 24